Dr. Rui Chen is currently Research Scientist in the Department of Genetics at Stanford University, sponsored by Dr. Michael Snyder. Dr. Chen has extensive experience in disease-related research and disease-orientated technology development, and is spearheading personalized health monitoring and preventative medicine with next-generation, high-throughput technologies. Dr. Chen orchestrated the first personalized health monitoring and preventative medicine proof-of-principle study with integrative omics, which was published as the only research paper in the 2012 special issue of Cell. This paper was later selected as “Genome Advance of the Month” by the National Human Genome Research Institute (National Institutes of Health), and also into Cell—Best of 2012. Beyond integrative personal omics research, Dr. Chen has broad expertise in cancer immunology and chemoresistance, and disease-related research such as asthma, Myelodysplastic Syndromes, as well as rare Mendelian diseases. Dr. Rui Chen completed his Ph.D. at Yale University in 2008 with the John Spangler Nicholas Prize, a prestigious award for most outstanding Ph.D. candidates in Biology.
Google Scholar Profile (Click Here)